Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates

Rhea-AI Summary

Jaguar Health (NASDAQ:JAGX) has announced an upcoming investor webcast scheduled for Thursday, May 15, 2025, at 4:15 PM Eastern Time. The company will use this webcast to review its first-quarter 2025 financial results and provide corporate updates. The company plans to file its Form 10-Q earnings report for the quarter ended March 31, 2025, on May 15, 2025.

Click here to register

Company plans to file its Earnings Report on May 15, 2025 on Form 10-Q for the quarter ended March 31, 2025

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / May 14, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast tomorrow, Thursday, May 15, 2025, at 4:15 p.m. Eastern to review first-quarter 2025 financials and provide corporate updates.

Participation Instructions for Investor Webcast

When: Thursday, May 15, 2025 at 4:15 PM Eastern Standard Time

Participant Registration & Access Link: Click Here

About the Jaguar Health Family of Companies

Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi^® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan and/or rare diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.

For more information about:

Jaguar Health, visit https://jaguar.health

Napo Pharmaceuticals, visit www.napopharma.com

Napo Therapeutics, visit napotherapeutics.com

Magdalena Biosciences, visit magdalenabiosciences.com

Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements." These include statements regarding the expectation that Jaguar will file its 10-Q on May 15, 2025 for the quarter ended March 31, 2025, and the expectation that Jaguar will hold an investor webcast on May 15, 2025. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

hello@jaguar.health

Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

View the original press release on ACCESS Newswire

FAQ

When is Jaguar Health (JAGX) hosting its Q1 2025 earnings webcast?

Jaguar Health is hosting its Q1 2025 earnings webcast on Thursday, May 15, 2025, at 4:15 PM Eastern Time.

What will be discussed in Jaguar Health's (JAGX) May 15 investor webcast?

The webcast will review Jaguar Health's first-quarter 2025 financial results and provide corporate updates.

When will Jaguar Health (JAGX) file its Q1 2025 earnings report?

Jaguar Health plans to file its Q1 2025 earnings report (Form 10-Q) on May 15, 2025, for the quarter ended March 31, 2025.

How can investors access Jaguar Health's (JAGX) Q1 2025 earnings webcast?

Investors can access the webcast by clicking the registration and access link provided in the announcement.